Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: A critical review

American Journal of Geriatric Psychiatry

Volumn 21, Issue 10, 2013, Pages 973-986

  Maust, Donovan T ^a   Oslin, David W ^a,b   Thase, Michael E ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Augmentation; Depression; Pharmacotherapy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LITHIUM; LITHIUM CARBONATE; MAPROTILINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PERPHENAZINE; PHENELZINE; RISPERIDONE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ARTICLE; CLINICAL PRACTICE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; DIZZINESS; DRUG BLOOD LEVEL; DRUG COMBINATION; HUMAN; LATE LIFE DEPRESSION; MAINTENANCE THERAPY; MAJOR DEPRESSION; MONOTHERAPY; POLYPHARMACY; TREATMENT RESPONSE; TREMOR; UNSTEADINESS;

ANTIDEPRESSANT; AUGMENTATION; DEPRESSION; PHARMACOTHERAPY;

AGING; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM COMPOUNDS; REMISSION INDUCTION;

EID: 84884589551     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.01.030     Document Type: Article

References (58)

1. Ganguli M, Dodge HH, Mulsant BH: Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry 2002; 59: 1046-1052
2. Pulska T, Pahkala K, Laippalla P, et al: Major depression as a predictor of premature deaths in elderly people in Finland: a community study. Acta Psychiatr Scand 1998; 97: 408-411
3. Romanelli J, Fauerbach JA, Bush DE, et al: The significance of depression in older patients after myocardial infarction. J Am Geriatr Soc 2002; 50: 817-822
4. O'Connor CM, Jiang W, Kuchibhatla M, et al: Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008; 168: 2232-2237
5. Black SA, Markides KS, Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with Type 2 diabetes. Diabetes Care 2003; 26: 2822-2828
6. Alexopoulos G, Vrontou C, Kakuma T, et al: Disability in geriatric depression. Am J Psychiatry 1996; 153: 877-885
7. Bruce ML, Seeman TE, Merrill SS, et al: The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. Am J Public Health 1994; 84: 1796-1799
8. Bao Y, Post EP, Ten TR, et al: Achieving effective antidepressant pharmacotherapy in primary care: the role of depression care management in treating late-life depression. J Am Geriatr Soc 2009; 57: 895-900
9. Unutzer J, Katon W, Callahan CM, et al: Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002; 288: 2836-2845
10. Oxman TE, Dietrich AJ, Schulberg HC: The depression care manager and mental health specialist as collaborators within primary care. Am J Geriatr Psychiatry 2003; 11: 507-516
11. Wilson K, Mottram P, Sivanranthan A, et al: Antidepressants versus placebo for the depressed elderly. Cochrane Database Syst Rev 2001; (2):CD000561. DOI: 10.1002/14651858.CD000561
12. Roose SP, Schatzberg AF: The efficacy of antidepressants in the treatment of late-life depression. J Clin Psychopharmacol 2005; 25:S1-S7
13. Reynolds C 3rd, Frank E, Kupfer D, et al: Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients. Am J Psychiatry 1996; 153: 1288-1292
14. Reynolds CF 3rd, Dew MA, Pollock BG, et al: Maintenance treatment of major depression in old age. N Engl J Med 2006; 354: 1130-1138
15. Alexopoulos GS: Depression in the elderly. Lancet 2005; 365: 1961-1970
16. Mulsant BH, Pollock BG: Treatment-resistant depression in late life. J Geriatr Psychiatry Neurol 1998; 11: 186-193
17. Flint AJ, Rifat SL: The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996; 36: 95-105
18. Kok RM, Nolen WA, Heeren TJ: Outcome of late-life depression after 3 years of sequential treatment. Acta Psychiatr Scand 2009; 119: 274-281
19. Gaynes BN, Warden D, Trivedi MH, et al: What did STAR*D teach us? results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 2009; 60: 1439-1445
20. Rush AJ: Star-D: lessons learned and future implications. Depress Anxiety 2011; 28: 521-524
21. Pincus HA, Tanielian TL, Marcus SC, et al: Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998; 279: 526-531
22. Mojtabai R, Olfson M: National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010; 67: 26-36
23. Trivedi MH, Fava M, Wisniewski SR, et al: Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006; 354: 1243-1252
24. Lam RW, Hossie H, Solomons K, et al: Citalopram and bupropion- SR: combining versus switching in patients with treatmentresistant depression. J Clin Psychiatry 2004; 65: 337-340
25. Crossley NA, Bauer M: Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 2007; 68: 935-940
26. de Montigny C, Cournoyer G, Morissette R, et al: Lithium carbonate addition in tricyclic antidepressanteresistant unipolar depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry 1983; 40: 1327-1334
27. Nierenberg AA, Fava M, Trivedi MH, et al: A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006; 163: 1519-1530
28. Aronson R, Offman HJ, Joffe RT, et al: Triiodothyronine augmentation in the treatment of refractory depression. A metaanalysis. Arch Gen Psychiatry 1996; 53: 842-848
29. Nelson JC, Papakostas GI: Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009; 166: 980-991
30. Pollock BG: The pharmacokinetic imperative in late-life depression. J Clin Psychopharmacol 2005; 25:S19-S23
31. Lotrich FE, Pollock BG: Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol 2005; 45: 1106-1122
32. Doody RS, Stevens JC, Beck C, et al: Practice parameter: management of dementia (an evidence-based review). Neurology 2001; 56: 1154-1166
33. Kushnir S: Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 1986; 143: 378-379
34. Lafferman J, Solomon K, Ruskin P: Lithium augmentation for treatment-resistant depression in the elderly. J Geriatr Psychiatry Neurol 1988; 1: 49-52
35. Finch EJL, Katona CLE: Lithium augmentation in the treatment of refractory depression in old age. Int J Geriatr Psychiatry 1989; 4: 41-46
36. van Marwijk HWJ, Bekker FM, Nolen WA, et al: Lithium augmentation in geriatric depression. J Affect Disord 1990; 20: 217-223
37. Zimmer B, Rosen J, Thornton JE, et al: Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol 1991; 11: 254-256
38. Flint AJ, Rifat SL: A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994; 14: 353-356
39. Whyte EM, Basinski J, Farhi P, et al: Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65: 1634-1641
40. Dew MA, Whyte EM, Lenze EJ, et al: Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 2007; 164: 892-899
41. Kok RM, Vink D, Heeren TJ, et al: Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. J Clin Psychiatry 2007; 68: 1177-1185
42. Shelton RC, Tollefson GD, Tohen M, et al: A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001; 158: 131-134
43. Rutherford B, Sneed J, Miyazaki M, et al: An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. Int J Geriatr Psychiatry 2007; 22: 986-991
44. Sheffrin M, Driscoll HC, Lenze EJ, et al: Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. J Clin Psychiatry 2009; 70: 208-213
45. National Institute of Mental Health, University of Pittsburgh: Incomplete response in late life depression: getting to remission, in ClinicalTrials gov. Bethesda, MD, National Library of Medicine (US). Available at: http://clinicaltrials.gov/ct2/show/ NCT00892047; NLM Identifier: NCT00892047. Accessed August 17, 2011
46. Lavretsky H, Kumar A: Methylphenidate augmentation of citalopram in elderly depressed patients. Am J Geriatr Psychiatry 2001; 9: 298-303
47. Lavretsky H, Kim MD, Kumar A, et al: Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry 2003; 64: 1410-1414
48. Lavretsky H, Park S, Siddarth P, et al: Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a doubleblind, placebo-controlled pilot trial. Am J Geriatr Psychiatry 2006; 14: 181-185
49. Hardy BG, Shulman KI, Zucchero C: Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression. J Clin Psychopharmacol 1997; 17: 22-26
50. Fahy S, Lawlor BA: Discontinuation of lithium augmentation in an elderly cohort. Int J Geriatr Psychiatry 2001; 16: 1004-1009
51. Reynolds C 3rd, Frank E, Perel J, et al: High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996; 153: 1418-1422
52. Alexopoulos GS, Canuso CM, Gharabawi GM, et al: Placebocontrolled study of relapse prevention with risperidone augmentation in older patients with resistant depression. Am J Geriatr Psychiatry 2008; 16: 21-30
53. Food and Drug Administration: Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/Drug SafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ ucm053171.htm. Accessed March 4, 2011
54. Rush AJ, Trivedi MH, Stewart JW, et al: Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011; 168: 689-701
55. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
56. Chambers DA, Wang PS, Insel TR: Maximizing efficiency and impact in effectiveness and services research. Gen Hosp Psychiatry 2010; 32: 453-455
57. Valenstein M, McCarthy JF, Austin KL, et al: What happened to lithium? Antidepressant augmentation in clinical settings. Am J Psychiatry 2006; 163: 1219-1225
58. Maust DT, Mavandadi S, Eakin A, et al: Telephone-based behavioral health assessment for older adults starting a new psychiatric medication. Am J Geriatr Psychiatry 2011; 19: 851-858